The Food and Drug Administration (FDA) on Tuesday granted expanded approval to Wellcovorin for the ultra-rare disease ...

FDA approves leucovorin as the first treatment for FOLR1-related cerebral folate deficiency, while evidence remains insufficient for autism treatment.

The FDA declined to endorse leucovorin as a treatment for autism, but approved the drug to treat cerebral folate deficiency, ...

Cerebral folate deficiency is a rare neurological disorder characterized by a decrease in CSF folate levels, leading to developmental regression, seizures, movement disorders, and other neurological ...

The prescription drug leucovorin is getting a label update, though it’s not what that the US Food and Drug Administration suggested might be coming during a White House briefing in September, when ...

The FDA announced a new approved use for the drug leucovorin, which Trump has touted as a treatment for autism. But the ...

About five months after U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. | About five months after U.S. Health Secretary Robert F. Kennedy Jr. touted leucovorin as “an ...

The FDA narrowed leucovorin's use to a rare disorder, a major shift after Trump and RFK Jr. promoted it for autism.

By Ahmed Aboulenein and Julie Steenhuysen WASHINGTON, March 10 (Reuters) - The U.S. FDA on Tuesday approved leucovorin, a ...

FDA says data insufficient to approve leucovorin for autism.

The NHS has highlighted several warning signs of iron deficiency anaemia, with two particular symptoms that show up while a ...

Six months ago, the federal government loudly proclaimed the likely benefits of an existing drug called leucovorin for treating autism. Now that proclamation has officially turned into a whimper. On ...